What Is The GS Discovery® Transient Expression System?
Transient gene expression can offer a fast path to material generation in early biotherapeutic development, but achieving both speed and high titers is a challenge. In this video, Peter O'Callaghan, Senior Director and Head of Expression System Sciences, Licensing, explores Lonza's GS Discovery® transient expression platform and the technologies designed to improve its performance and consistency.
The discussion covers two approaches within the platform: a standard chemical transfection process that generates material in roughly 8–10 days, and a novel GS piggyBac®-powered process built to prioritize higher titers.
O'Callaghan also explains how the platform uses the same host cells, expression vectors, and transposase technology as Lonza's broader GS Gene Expression System® platform, creating consistency in product quality between transient and stable expression workflows. This supports a more streamlined path from early material generation through stable pool and clonal cell line development.
Watch the full video to learn how GS Discovery® combines ease of use, rapid timelines, high-titer potential, and platform consistency to support biotherapeutic development.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.